Working… Menu

Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02808208
Recruitment Status : Enrolling by invitation
First Posted : June 21, 2016
Last Update Posted : July 26, 2021
Information provided by (Responsible Party):
Sanjay Misra, M.D., Mayo Clinic

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021